Changing the Conversation: Immunotherapy and Long-Term Survival

Morganna Freeman, DO, FACP

Video Categories: 2018 AONN Midyear, Immunotherapy, and Video Library

Dr Morganna Freeman discusses some of the ways immunotherapy has changed cancer care, including the expectation for long-term survival and how to treat patients in remission.

October 28, 2014

Options for Patients with Polycythemia Vera

Hear Dr. Mesa discuss options available for individual patients who have failed hydroxyurea polycythemia vera.Supported through funding from Incyte

July 25, 2018

Biomarker Data in Melanoma Presented at ASCO 2018 Are Largely Extensions of Previous Studies Rather Than New Discoveries

Dr Sanjiv Agarwala argues that much of the biomarker data in melanoma presented at ASCO 2018 are around the value of PD-L1 testing; however, even PD-L1–negative melanoma patients seem to respond to anti–PD-1 therapy, although some studies suggest PD-L1–negative patients may be better candidates for combination immunotherapy.